We are appropriately cautious, but this is one of the more genuinely promising developments in osteoarthritis research in recent memory. And, he says, the results are not just because of weight loss
The technical accuracyyes, this increases GLP-1creates misleading impressions when magnitude, duration, and biological significance remain unaddressed
Here we see its superiority in terms of glycated haemoglobin, 1.91 versus 1.47, and also something very important in terms of weight loss
Topline Eli Lilly, the GLP-1 maker behind Mounjaro and Zepbound, said it would file for Food and Drug Administration approval of its powerful retatrutide weight-loss drug after studies found participants lost an average of nearly 56 pounds after 80 weeks on the medication
The tablet needs time to be absorbed in your stomach for it to be effective